Bolei Dai

590 total citations
11 papers, 500 citations indexed

About

Bolei Dai is a scholar working on Immunology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Bolei Dai has authored 11 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 4 papers in Molecular Biology and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Bolei Dai's work include Immunotherapy and Immune Responses (4 papers), Phagocytosis and Immune Regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Bolei Dai is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Phagocytosis and Immune Regulation (3 papers) and Ferroptosis and cancer prognosis (3 papers). Bolei Dai collaborates with scholars based in China. Bolei Dai's co-authors include Zhihong Zhang, Qingming Luo, Guoqiang Xu, Xiang Yu, Yanfeng Dai, Sha Qiao, Lisen Lu, Yuan Qian, Jianqiao Liu and Lu Chen and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and ACS Nano.

In The Last Decade

Bolei Dai

11 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bolei Dai China 7 281 224 171 101 74 11 500
Samuel S.K. Lam United States 11 280 1.0× 134 0.6× 136 0.8× 151 1.5× 40 0.5× 17 502
Chu-Chi Lin Taiwan 5 118 0.4× 101 0.5× 124 0.7× 52 0.5× 64 0.9× 7 280
Francesca Piaggio Italy 11 150 0.5× 64 0.3× 206 1.2× 103 1.0× 56 0.8× 16 475
Karthik Tiruthani United States 11 314 1.1× 228 1.0× 295 1.7× 279 2.8× 94 1.3× 17 746
Suke Deng China 7 147 0.5× 90 0.4× 216 1.3× 124 1.2× 42 0.6× 11 409
Armin Ahmadi United States 12 153 0.5× 120 0.5× 233 1.4× 126 1.2× 77 1.0× 23 511
Yiting Feng China 5 277 1.0× 66 0.3× 178 1.0× 194 1.9× 19 0.3× 15 523
Zhifa Wen China 14 316 1.1× 113 0.5× 255 1.5× 137 1.4× 29 0.4× 24 550
Anne Showalter United States 4 122 0.4× 96 0.4× 141 0.8× 119 1.2× 19 0.3× 6 350
Christina Kittipatarin United States 7 218 0.8× 90 0.4× 107 0.6× 166 1.6× 15 0.2× 7 419

Countries citing papers authored by Bolei Dai

Since Specialization
Citations

This map shows the geographic impact of Bolei Dai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bolei Dai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bolei Dai more than expected).

Fields of papers citing papers by Bolei Dai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bolei Dai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bolei Dai. The network helps show where Bolei Dai may publish in the future.

Co-authorship network of co-authors of Bolei Dai

This figure shows the co-authorship network connecting the top 25 collaborators of Bolei Dai. A scholar is included among the top collaborators of Bolei Dai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bolei Dai. Bolei Dai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Dai, Bolei, et al.. (2024). Iberverin Downregulates GPX4 and SLC7A11 to Induce Ferroptotic Cell Death in Hepatocellular Carcinoma Cells. Biomolecules. 14(11). 1407–1407. 6 indexed citations
2.
Yu, Wenjia, et al.. (2024). MDH2 Promotes Hepatocellular Carcinoma Growth Through Ferroptosis Evasion via Stabilizing GPX4. International Journal of Molecular Sciences. 25(21). 11604–11604. 4 indexed citations
3.
Han, Chenlu, Yuke Wang, Xuwen Peng, et al.. (2024). Intravital imaging of splenic classical monocytes modifying the hepatic CX3CR1+ cells motility to exacerbate liver fibrosis via spleen-liver axis. Theranostics. 14(5). 2210–2231. 2 indexed citations
4.
Li, Donglin, et al.. (2024). Natural Product Auraptene Targets SLC7A11 for Degradation and Induces Hepatocellular Carcinoma Ferroptosis. Antioxidants. 13(8). 1015–1015. 7 indexed citations
5.
Dai, Bolei, et al.. (2023). Advances in intravital imaging of liver immunity using optical microscopy and labeling methods. SHILAP Revista de lepidopterología. 1(1). 61–77. 4 indexed citations
6.
Dai, Bolei, Ren Zhang, Shuhong Qi, et al.. (2022). Intravital molecular imaging reveals that ROS-caspase-3-GSDME-induced cell punching enhances humoral immunotherapy targeting intracellular tumor antigens. Theranostics. 12(17). 7603–7623. 11 indexed citations
8.
Liu, Lei, Bolei Dai, Ruixue Li, Zheng Liu, & Zhihong Zhang. (2020). Intravital molecular imaging reveals the restrained capacity of CTLs in the killing of tumor cells in the liver. Theranostics. 11(1). 194–208. 12 indexed citations
9.
Yu, Xiang, Lu Chen, Jianqiao Liu, et al.. (2019). Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis. Nature Communications. 10(1). 574–574. 119 indexed citations
10.
Lin, Qiaoya, Xianlin Song, Bolei Dai, et al.. (2019). Self-Assembled “Off/On” Nanopomegranate for In Vivo Photoacoustic and Fluorescence Imaging: Strategic Arrangement of Kupffer Cells in Mouse Hepatic Lobules. ACS Nano. 13(2). 1526–1537. 20 indexed citations
11.
Qian, Yuan, Sha Qiao, Yanfeng Dai, et al.. (2017). Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages. ACS Nano. 11(9). 9536–9549. 300 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026